Login
Home
Charts
Search
Watchlist
Products

Premier Explosives Ltd

PREMEXPLN·NSE
674.25-0.13%Tue, 22 Sept '26

Premier Explosives Ltd

PREMEXPLN
NSE
674.25
-0.13%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
3,621Cr
Close
Close Price
673.50
Industry
Industry
Industrial Explosives
PE
Price To Earnings
107.93
PS
Price To Sales
10.38
Revenue
Revenue
349Cr
Rev Gr TTM
Revenue Growth TTM
-26.85%
PAT Gr TTM
PAT Growth TTM
-8.76%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
784587839516674142768189103
Growth YoY
Revenue Growth YoY%
29.319.565.933.820.6272.4-14.671.5-20.1-50.920.4-27.9
Expenses
ExpensesCr
57407267781506512169709097
Operating Profit
Operating ProfitCr
22515161715102171206
OPM
OPM%
27.910.917.418.717.69.312.914.78.614.3-0.45.7
Other Income
Other IncomeCr
03111012220132
Interest Expense
Interest ExpenseCr
322334111111
Depreciation
DepreciationCr
333333333333
PBT
PBTCr
162111112961925894
Tax
TaxCr
514340237221
PAT
PATCr
122778941518673
Growth YoY
PAT Growth YoY%
348.5168.8179.0-11.3-27.7436.6-44.7109.5111.2-34.075.5-80.0
NPM
NPM%
14.93.97.88.88.95.65.110.823.67.57.43.0
EPS
EPS
0.40.31.31.41.61.70.72.93.31.11.20.6
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
784587839516674142768189103
Growth YoY
Revenue Growth YoY%
29.319.565.933.820.6272.4-14.671.5-20.1-50.920.4-27.9
Expenses
ExpensesCr
57407267781506512169709097
Operating Profit
Operating ProfitCr
22515161715102171206
OPM
OPM%
27.910.917.418.717.69.312.914.78.614.3-0.45.7
Other Income
Other IncomeCr
03111012220132
Interest Expense
Interest ExpenseCr
322334111111
Depreciation
DepreciationCr
333333333333
PBT
PBTCr
162111112961925894
Tax
TaxCr
514340237221
PAT
PATCr
122778941518673
Growth YoY
PAT Growth YoY%
348.5168.8179.0-11.3-27.7436.6-44.7109.5111.2-34.075.5-80.0
NPM
NPM%
14.93.97.88.88.95.65.110.823.67.57.43.0
EPS
EPS
0.40.31.31.41.61.70.72.93.31.11.20.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
185238275253165154199202272417388349
Growth
Revenue Growth%
28.515.5-7.8-35.0-6.629.61.534.553.6-7.0-26.9
Expenses
ExpensesCr
167208255230170147178176213359350325
Operating Profit
Operating ProfitCr
18302023-56212658583924
OPM
OPM%
9.512.47.19.2-3.34.110.512.821.513.99.96.8
Other Income
Other IncomeCr
-21231-832423737
Interest Expense
Interest ExpenseCr
44566779111133
Depreciation
DepreciationCr
344456101012111212
PBT
PBTCr
8221316-15-157941386046
Tax
TaxCr
3755-5-4221291512
PAT
PATCr
615811-10-115728294634
Growth
PAT Growth%
170.5-47.340.6-189.0-9.3147.733.4308.01.159.5-8.8
NPM
NPM%
3.06.42.94.5-6.1-7.12.63.510.56.911.89.6
EPS
EPS
1.33.61.52.1-1.9-2.01.01.35.35.38.56.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
185238275253165154199202272417388349
Growth
Revenue Growth%
28.515.5-7.8-35.0-6.629.61.534.553.6-7.0-26.9
Expenses
ExpensesCr
167208255230170147178176213359350325
Operating Profit
Operating ProfitCr
18302023-56212658583924
OPM
OPM%
9.512.47.19.2-3.34.110.512.821.513.99.96.8
Other Income
Other IncomeCr
-21231-832423737
Interest Expense
Interest ExpenseCr
44566779111133
Depreciation
DepreciationCr
344456101012111212
PBT
PBTCr
8221316-15-157941386046
Tax
TaxCr
3755-5-4221291512
PAT
PATCr
615811-10-115728294634
Growth
PAT Growth%
170.5-47.340.6-189.0-9.3147.733.4308.01.159.5-8.8
NPM
NPM%
3.06.42.94.5-6.1-7.12.63.510.56.911.89.6
EPS
EPS
1.33.61.52.1-1.9-2.01.01.35.35.38.56.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
99111111111111111111
Reserves
ReservesCr
57116187199186174179184209235278
Current Liabilities
Current LiabilitiesCr
576984639288114142184249157
Non Current Liabilities
Non Current LiabilitiesCr
725252417211718363236
Total Liabilities
Total LiabilitiesCr
130220309299307294322356442528483
Current Assets
Current AssetsCr
77105181136119101127159235319258
Non Current Assets
Non Current AssetsCr
52114128163188193195197207209225
Total Assets
Total AssetsCr
130220309299307294322356442528483
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
99111111111111111111
Reserves
ReservesCr
57116187199186174179184209235278
Current Liabilities
Current LiabilitiesCr
576984639288114142184249157
Non Current Liabilities
Non Current LiabilitiesCr
725252417211718363236
Total Liabilities
Total LiabilitiesCr
130220309299307294322356442528483
Current Assets
Current AssetsCr
77105181136119101127159235319258
Non Current Assets
Non Current AssetsCr
52114128163188193195197207209225
Total Assets
Total AssetsCr
130220309299307294322356442528483

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
10-7-2450-610-22179118-1
Investing Cash Flow
Investing Cash FlowCr
-4-9-46-26-14-4-11-16-25-11-27
Financing Cash Flow
Financing Cash FlowCr
-31471-2420-713-6-34-34-14
Net Cash Flow
Net Cash FlowCr
3-310-1-1002073-42
Free Cash Flow
Free Cash FlowCr
11-15-3912-36-3-15756105-29
CFO To PAT
CFO To PAT%
181.7-44.4-298.3445.763.9-90.8-41.3303.2277.8412.3-2.8
CFO To EBITDA
CFO To EBITDA%
58.2-22.8-121.9216.1117.3157.4-10.381.5135.0204.4-3.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
10-7-2450-610-22179118-1
Investing Cash Flow
Investing Cash FlowCr
-4-9-46-26-14-4-11-16-25-11-27
Financing Cash Flow
Financing Cash FlowCr
-31471-2420-713-6-34-34-14
Net Cash Flow
Net Cash FlowCr
3-310-1-1002073-42
Free Cash Flow
Free Cash FlowCr
11-15-3912-36-3-15756105-29
CFO To PAT
CFO To PAT%
181.7-44.4-298.3445.763.9-90.8-41.3303.2277.8412.3-2.8
CFO To EBITDA
CFO To EBITDA%
58.2-22.8-121.9216.1117.3157.4-10.381.5135.0204.4-3.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
337310356263671693344341,6321,8102,0493,621
Price To Earnings
Price To Earnings
63.719.743.723.262.962.857.612.644.7107.9
Price To Sales
Price To Sales
1.81.31.31.00.41.11.72.16.04.35.310.4
Price To Book
Price To Book
5.22.51.81.30.30.91.82.27.41.57.112.5
EV To EBITDA
EV To EBITDA
20.111.618.411.1-19.534.919.419.728.530.252.3150.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
41.340.133.635.540.346.644.849.352.937.6
OPM
OPM%
9.512.47.19.2-3.34.110.512.821.513.99.96.8
NPM
NPM%
3.06.42.94.5-6.1-7.12.63.510.56.911.89.6
ROCE
ROCE%
13.716.47.49.1-3.7-3.35.36.618.117.019.919.9
ROE
ROE%
8.612.24.15.4-5.1-5.92.83.612.911.715.815.8
ROA
ROA%
4.36.92.63.8-3.3-3.71.62.06.45.49.59.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
337310356263671693344341,6321,8102,0493,621
Price To Earnings
Price To Earnings
63.719.743.723.262.962.857.612.644.7107.9
Price To Sales
Price To Sales
1.81.31.31.00.41.11.72.16.04.35.310.4
Price To Book
Price To Book
5.22.51.81.30.30.91.82.27.41.57.112.5
EV To EBITDA
EV To EBITDA
20.111.618.411.1-19.534.919.419.728.530.252.3150.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
41.340.133.635.540.346.644.849.352.937.6
OPM
OPM%
9.512.47.19.2-3.34.110.512.821.513.99.96.8
NPM
NPM%
3.06.42.94.5-6.1-7.12.63.510.56.911.89.6
ROCE
ROCE%
13.716.47.49.1-3.7-3.35.36.618.117.019.919.9
ROE
ROE%
8.612.24.15.4-5.1-5.92.83.612.911.715.815.8
ROA
ROA%
4.36.92.63.8-3.3-3.71.62.06.45.49.59.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Premier Explosives began as a mining-supplies company in 1980, but its real story starts in 2003 when it became one of the first private Indian firms to make solid propellants for missiles - a move that turned it into a critical partner for the country’s defence and space programmes. Today it is a manufacturer of high-energy materials - the stuff that powers missiles, separates rocket stages, detonates warheads, and breaks rock in mines - with a recurring approach of qualifying as a sole or first-mover supplier on strategically sensitive products, then riding long government qualification cycles as a moat. # Business segments Two engines, one order book - a defence-and-space powerhouse that supplies propellants, warheads and countermeasures to India’s missile and rocket programmes, and a commercial explosives business that sells detonators and bulk explosives to mines and construction sites. ## 1. Defence & Space: the propellant and countermeasures backbone of India’s missile programmes **The company is the sole Indian supplier of solid propellants for several frontline missiles and the only qualified domestic maker of chaff and flare countermeasures - once qualified, these products are rarely re-tendered, creating a multi-decade revenue stream.** - **Sole-source propellants** - PEL provides 100% of the solid propellant requirements for the MRSAM (Army), LRSAM (Navy) and Astra (Air Force) missile programmes, supplying directly to DRDO and Bharat Dynamics. For the Akash surface-to-air missile, it has delivered over 2,500 booster grains and 450 sustainer grains, and for the Agni ballistic missile it supplies pyrogen igniters for every stage. - **The only domestic countermeasures maker** - PEL is the sole qualified Indian company for chaffs and flares, the decoys that protect aircraft from incoming missiles, and it has backward-integrated many of the components in-house. No other domestic firm is qualified to compete. - **From igniters to fully assembled rockets** - the product range spans pyrogen igniters, case-bonded propellants, gas generators, and rocket motors from 40 mm to 2,000 mm in diameter, plus warheads, mines, and ammunition including the Nipun Mine. The company has also started exporting fully assembled rocket motors, with a single export order worth about ₹350 crore secured in April 2026. - **Runs the government’s own plants** - under the GOCO (Government-Owned Company-Operated) model, PEL operates and maintains solid propellant facilities at ISRO’s Sriharikota launch centre and at DRDO’s Advanced Systems Laboratory in Jagdalpur, relationships that have run for 17 years or more. - **Space is a customer too** - PEL makes the PSOM-XL strap-on motors for ISRO’s PSLV rocket and was the first private enterprise to be qualified for complete insulation lining and propellant processing of those motors for a live launch. ## 2. Commercial Explosives: detonators and bulk explosives for mines and construction **A competitive, tender-driven business selling to coal and cement companies - lower margin than defence, but it keeps the company’s explosives manufacturing base running at scale.** - **Safer detonators, invented in-house** - PEL was the first company in the world to manufacture NHN-based detonators on a commercial scale, a greener and less shock-sensitive alternative to traditional ASA detonators. It produced about 10 million detonators and over 8,500 tonnes of bulk explosives in FY25. - **Sells to India’s biggest miners** - domestic customers include Coal India, Singareni Collieries, Neyveli Lignite, and cement manufacturers, with exports to countries such as Israel, Greece, Turkey, Thailand and Indonesia. Contracts with Coal India include price escalation clauses, so raw-material cost swings are partly passed through. - **Selective bidding in a crowded field** - with more than 40 players in the market, the company bids only when margins are acceptable and has previously walked away from tenders when raw-material prices spiked. The business faces intensive competition and carries lower margins than the defence segment. - **Four bulk-explosives plants near the customer** - manufacturing sites at Singrauli, Chandrapur, Godavarikhani and Manuguru sit close to mining basins, while detonators and packaged explosives are made at the Peddakandukur unit in Telangana. # Group structure and partners **PEL operates as the parent with a clean structure - one dormant subsidiary, one defunct wire business, and a new joint venture with a defence manufacturer to expand capacity.** - A 100% subsidiary, PELNEXT Defence Systems, was incorporated in 2016 as a special-purpose vehicle for defence explosives and incurred a net loss of Rs. 0.91 lakh during 2024-25. - An 80% subsidiary, Premier Wire Products, made galvanised iron wire for detonator manufacturers but closed its factory and dismissed all employees during FY22 after demand collapsed. - In March 2025, PEL formed a joint venture, Global Premier Limited, with Global Munition Limited (a NIBE Group subsidiary), with PEL holding 49% and Global Munition holding 51% and nominating three of five board directors; the JV will manufacture defence and aerospace products. - An earlier joint venture with Bharat Forge’s Kalyani Strategic Systems was struck off in November 2023 after failing to become operational. - PEL has signed strategic MoUs with Hindustan Aeronautics Limited for bomb and missile explosives, and with Astra Microwave Products for joint development and sale of multiple products.

Documents — Premier Explosives Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/ut1t3zr593wqy1wiggfn2fi3.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/8mwbtkrmoay57npta8nhtulf.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/8m6xooipl00f7mwi19xddpgl.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/12o5ss2g9byuktmy7xa00d6f.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/om6w7wf9ppt1r1w6gin7yw8v.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/dsnkgf1zaqpt4mrsrjaoi087.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/px40r94icqhe791g7icpsbad.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/i6xt4bh3w48ug0yx7oh4wxfg.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/o8oyqmd5omg5gxhe9ccl06a2.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/w6lv28vx9jdz0a5soe3dxs6e.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/bg5110t7gf9ii1y23onupxwi.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/5ayq0rb221waefdqbe5ld1mx.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/rkxzv803891lptlnf0w0ev78.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/huxr07208v48yha131wc5fa1.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/1ijhrhul0ng618ird58r3cx8.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/be1x6ez9efn4k4n4bx85mso8.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/3wtucd4g8i3vfatbor1jzbto.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/vnle6iq84emqf6rs27fagv08.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/88687cxeqffvc3ownq4d2bgs.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/327krnh5s1loz0sxp78hqqv1.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/edkr3qzkjb6ib8oc0sv5jxai.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/m6kp5d7cx1wkeoc8g5egidq8.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/sxdcfr5fsunfn61vv2p0aw3q.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/xmvvi3kpr89l6xenv6v055vf.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/0s6fpb1556fa3hnj11dvvz0x.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/dcybibtdegba4uyicyx3gyst.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/rc4ig301m7bbab6y8jwqg1qu.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/c5kvhug2cpzqqjh83litklo1.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/xrxicurzwnn49ofa9unlnuh1.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/2i34v2azpcsfw0x8kgec6x86.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/25art935f39snx8nclhd0qjl.pdf

Concall Transcript Summaries — Premier Explosives Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3APREMEXPLN/transcript-notes/202606/ut1t3zr593wqy1wiggfn2fi3.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3APREMEXPLN/transcript-notes/202603/8mwbtkrmoay57npta8nhtulf.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3APREMEXPLN/transcript-notes/202512/8m6xooipl00f7mwi19xddpgl.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3APREMEXPLN/transcript-notes/202509/12o5ss2g9byuktmy7xa00d6f.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3APREMEXPLN/transcript-notes/202506/om6w7wf9ppt1r1w6gin7yw8v.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3APREMEXPLN/transcript-notes/202503/dsnkgf1zaqpt4mrsrjaoi087.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3APREMEXPLN/transcript-notes/202412/px40r94icqhe791g7icpsbad.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3APREMEXPLN/transcript-notes/202409/i6xt4bh3w48ug0yx7oh4wxfg.pdf